Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trelegy Ellipta with Connected Inhaler System vs Standard Triple Therapy in Uncontrolled Asthma
NCT03376932Phase 3Withdrawn
- Sponsor
- GSK
- Start
- Jan 2019
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of fluticasone in asthma, sponsored by GSK. Planned start Jan 2019; status: withdrawn.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03376932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03376932.